Sponsor

Telik

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Telik appears in 7 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials7
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

7 shown
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung CancerNCT00701870 · lead sponsor · 2008-10-01
TERMINATED
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung CancerNCT00088556 · lead sponsor · 2004-08-01
COMPLETED
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)NCT00077883 · lead sponsor · 2004-02-01
COMPLETED
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung CancerNCT00047801 · lead sponsor · 2002-10-01
COMPLETED
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung CancerNCT00040638 · lead sponsor · 2002-07-01
COMPLETED
Phase 2 Study of TLK286 in Metastatic Breast CancerNCT00035841 · lead sponsor · 2002-04-01
COMPLETED
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00080340 · lead sponsor
COMPLETED

Sponsor roles

lead sponsor7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.